Christopher Peetz - Jan 9, 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jan 9, 2023
Transactions value $
-$106,390
Form type
4
Date filed
3/18/2024, 05:37 PM
Previous filing
Jan 5, 2023
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$106K -5.16K -5.31% $20.62 92K Jan 9, 2023 Direct F1, F2
holding MIRM Common Stock 209K Jan 9, 2023 By The Peetz Family Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.
F2 7,000 shares held indirectly by the reporting person were inadvertently reported on prior Form 4 filings as direct holdings. The reporting person's holdings on this Form 4 have been adjusted accordingly.